FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称ZUBOTAMIG
异名/同义词IMMUNOGLOBULIN G1 (101-GLYCINE,234-PHENYLALANINE,235-GLUTAMIC ACID,265-ALANINE,405-LEUCINE,DE-C-TERMINAL-LYSINE), ANTI-(HUMAN CD3 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL IGG1-HUCACAO-H101G-FEAL .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL IGG1-HUCACAO-H101G-FEAL .LAMBDA.-CHAIN, (234->226'),(237->229')-BIS(DISULFIDE) WITH IMMUNOGLOBULIN G1 (234-PHENYLALANINE,235-GLUTAMIC ACID,265-ALANINE,409-ARGININE) ANTI-(HUMAN B7 HOMOLOG 4 PROTEIN) (HUMAN MONOCLONAL IGG1-7724-084-N52S-FEAR .GAMMA.1-CHAIN) DISULFIDE WITH HUMAN MONOCLONAL IGG1-7724-084-N52S-FEAR .KAPPA.-CHAIN
RECOMBINANT BISPECIFIC HUMANISED IGG1 KAPPA ANTI-B7H4 MONOCLONAL ANTIBODY GEN1047 DS
ZUBOTAMIG
ZUBOTAMIG [INN]
CAS登记号2640279-10-1
物质唯一标识(Unique Ingredient Identifier)99MWR4VJT2
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型 / INGREDIENT SUBSTANCE
关联数据
  • 药品国际非专利名称数据库
扩展资源
©2006-2026 Drugfuture->FDA Global Substance Registration System